Research for the individualized treatment model of schizophrenia based on objective assessment

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000029047

Enrollment

Unknown

Registered

2020-01-12

Start date

2020-01-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

first-episode schizophrenia

Interventions

first-episode schizophrenia:no

control group:no

Eligibility

Sex/Gender

All

Age

16 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnostic criteria for dsm-5 schizophrenia, schizoid psychosis or schizoaffective psychosis; 2. age from 16 to 45 years old; 3. first attack, duration of disease less than 3 years; 4. never taking medication or continuous treatment with the same antipsychotics for less than 2 weeks informed consent.

Exclusion criteria

Exclusion criteria: 1. Physical examination and laboratory biochemical indicators or electroencephalogram, electrocardiogram serious abnormalities; 2. Pregnant or nursing women; 3. Extreme excitement, impulsiveness, or disagreement; 4. The researchers concluded that participants were likely to commit suicide or violence during the study; 5. Patients who received electroconvulsive therapy or magnetic stimulation therapy within six months.

Design outcomes

Primary

Measure	Time frame
PANSS;CGI;MMN;PPI;p50;eyemovement;	—

Countries

China

Contacts

Public ContactAnning Li

Anding Hospital Capital Medical University

anning.li@hotmail.com+86 13141209427

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026